The Best Multiple Sclerosis Medication!

Sdílet
Vložit
  • čas přidán 2. 06. 2024
  • 2:11 Rebif vs. Avonex
    3:17 Betaseron vs. Avonex
    3:54 Rebif 44mcg vs. Rebif 22cmg
    4:30 Copaxone vs. Avonex
    6:05 Copaxone vs Betaseron & Copaxone vs. Rebif
    6:41 Gilenya vs. Avonex
    8:23 Zeposia (ozanimod) vs. Avonex
    9:00 Tecfidera Vs. Copaxone
    10:22 Aubagio vs. Rebif
    11:18 Imuran Vs. Avonex
    12:16 Imuran vs. IFN
    12:55 Tysabri vs. Avonex
    14:53 Rebif + steroids
    16:04 Laquinimod vs. Avonex
    16:53 HSCT vs. Novantrone
    19:01 HSCT vs. other DMTs
    21:06 Lemtrada vs. Rebif
    22:24 methotrexate vs. Avonex
    23:16 Ocrevus vs. Rebif
    24:28 Mavenclad (cladribine) vs. IFN
    25:25 Ofatumumab vs. Aubagio
    27:43 FINAL RANKING
    Comment or ask questions below! I would be happy to answer!
    Subscribe on CZcams for more videos every Wednesday!
    Make video requests in the comments section!
    My book "Resilience in the Face of Multiple Sclerosis" on Amazon: www.amazon.com/dp/B07WP7H5LK
    Sources:
    HSCT review: www.ncbi.nlm.nih.gov/pmc/arti...
    ASCLEPIOS: onlinelibrary.ectrims-congres...
    Barry Singer’s post: / 1172489071903379461
    OPERA: www.nejm.org/doi/full/10.1056...
    Placebo controlled cladribine study (Clarity): www.nejm.org/doi/full/10.1056...
    The ONWARD (Oral Cladribine Added ON To Interferon beta-1a in Patients With Active Relapsing Disease): [phase II] nn.neurology.org/content/5/5/...
    Lemtrada vs. Rebif: (product label of Lemtrada, page 7) products.sanofi.us/Lemtrada/Le...
    Ozanimod vs. avonex: www.ncbi.nlm.nih.gov/pubmed/2...
    www.ncbi.nlm.nih.gov/pubmed/3...
    • 1) An examination of the results of the EVIDENCE, INCOMIN, and phase III studies of interferon beta products in the treatment of multiple sclerosis ; Timothy Vartanian, MD, PhD; Clinical Therapeutics Volume 25, Issue 1, January 2003, Pages 105-118
    • 2) Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis; M. Etemadifar,; Prof. M. Janghorbani,; V. Shaygannejad ; Journal of Neurology ; December 2007, Volume 254, Issue 12, pp 1723-1728
    • 3) Non-Inferiority of Azathioprine Versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis Patients: A Multicentric Randomized Trial (Main Trial). Abstract P460
    • 4) Drug Class Review: Disease-modifying Drugs for Multiple Sclerosis; Final Update 1 Report
    • Drug Class Reviews; Beth Smith, DO, Susan Carson, MPH, Rochelle Fu, PhD, Marian McDonagh, PharmD, Tracy Dana, MLS, Benjamin KS Chan, MS, Sujata Thakurta, MPA-HA, and Andrew Gibler, PharmD.; Portland (OR): Oregon Health & Science University; August 2010.
    • 5) Editorial found here: www.msforum.net/Site/ViewPDF/V...
    • 6) J Neurol. 2014 Feb 18. [Epub ahead of print] A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis. Vollmer TL1, www.ncbi.nlm.nih.gov/pubmed/24...
    Dr. Brandon Beaber is a board-certified neurologist with subspecialty training in multiple sclerosis and other immunological diseases of the nervous system. He is a partner in the Southern California Permanente Medical Group and practices in Downey, California (South Los Angeles). He has several publications on MS epidemiology and has participated in clinical trials for MS therapeutics. You can follow him on twitter @Brandon_Beaber where he regularly posts about MS news and research.
    Follow me on twitter: / brandon_beaber
    Music: INNER GRACE - Copyright 2018 Wilton Vought Source: Really Really Free Music Link: • Video T
    he video material by Dr. Brandon Beaber is general educational material on health conditions and is not intended to be used by viewers to diagnose or treat any individual's medical condition. Specifically, this material is not a substitute for individualized diagnostic and treatment advice by a qualified medical/health practitioner, licensed in your jurisdiction, who has access to the relevant information available from diagnostic testing, medical interviews, and a physical examination. To the extent that Dr. Beaber endorses any lifestyle change, behavioral intervention, or supplements, the viewer should consult with a qualified healthcare professional to determine the safety and efficacy of the intervention in light of their individualized information.
  • Věda a technologie

Komentáře • 213

  • @xaroumenotipota
    @xaroumenotipota Před 2 lety +2

    The ONWARD study is not comparing cladribine with inf-b, but the comparison is cladribine+inf-b vs placebo+inf-b. Please correct with a pinned comment. Thank you

  • @camrynmcgough2612
    @camrynmcgough2612 Před 3 lety +13

    I have MS and I was diagnosed at 15, I was first put on tecfidera, but relapsed on that. then went on tysabri, relapsed on that, then tried rebif and I relapsed on that too. then my neurologist put me on Ocrevus and I love it, I have stayed in remission for 4+ years with this medication.

  • @AaronBosterMD
    @AaronBosterMD Před 4 lety +35

    Excellent and Informative video.This may be my favorite thus far. Thank you for taking the time to create this!

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 4 lety +6

      Thanks! I actually got a lot of this data from a presentation I gave to my attendings as a fellow. Is there any major head-to-head trial that I left out? I found it incredibly hard to find a definitive source for these trials.

    • @Sbannmarie298
      @Sbannmarie298 Před 8 měsíci +2

      So cool to see the Jedi Masters connecting here!

  • @jason0998
    @jason0998 Před 4 lety +22

    Ocrevus gang checking in!

  • @andreawirtz2328
    @andreawirtz2328 Před 4 lety +1

    Thank you for putting this together! Gives sort of a readers digest version for non medical people that find it difficult to make sense of these charts.

  • @lifewithjenniferb
    @lifewithjenniferb Před 4 lety +4

    Thank you thank you thank you. I feel like you can read my mind. You always make the videos I need to see!!!

  • @Scarlett_84
    @Scarlett_84 Před 3 lety +11

    More than 20 dmds... we just need a CURE! Sick of this stupid disease

  • @justinegustafson9998
    @justinegustafson9998 Před rokem

    This video is so thorough and clear to understand. Thank you so much for putting this together. It really helps to understand and evaluate my options for treatment.

  • @kara7197
    @kara7197 Před 4 lety +4

    Very informative content. Thank you also for the index in the description!

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 4 lety +1

      :) I figured most people would not watch a 35 minute video.

  • @__Wanderer
    @__Wanderer Před 2 lety +2

    Thank you for these videos Dr. :)

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 2 lety

      No problem. Let me know if you have any video suggestions.

    • @__Wanderer
      @__Wanderer Před 2 lety

      @@DrBrandonBeaber I was wondering if there are natural methods to boost Treg cells / lowering B cells (besides DMTs) / increasing autophagy (through methods such as fasting) & if these can help slow down MS - your video on FMD was great! Definitely would love to see more research on that as it is something patients can control. I also think diet / taking proper supplements at least allows the body the best chance to deal with exogenous/indigenous stresses. I saw there were mice studies that showed a significant drop in B/T cells with 36 hr fasting (but for humans compensating for metabolism *7 that would be about 10 days...). Research was called "Fasting-Refeeding Impacts Immune Cell Dynamics and Mucosal Immune Responses".

  • @mg.1680
    @mg.1680 Před 4 lety +3

    Awesome summary! Good idea on the timestamps. 😊

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 4 lety +1

      I figured people would want to skip to the drug they are taking/considering.

  • @desiredecove5815
    @desiredecove5815 Před rokem

    I’m posting your CZcams channel in a support group- excellent information.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před rokem +1

      Thanks Desire

    • @desiredecove5815
      @desiredecove5815 Před rokem +1

      I’m trying to streamline things. And you’re always good for education , and occasionally a song 🎵 🤘🏻🤣💪🏻 thank you 🙏🏻 from all of us who have MS- or like your singing 🤷🏻‍♀️🎵

  • @mariekeoosterom8793
    @mariekeoosterom8793 Před 4 lety +4

    Wonderful video, amazing! Thank you for taking this effort. I wish I had this information 2 years ago when I was diagnosed and my neurologist sent me home with a list of DMTs to choose from. 'They all work about equally well' and that was it. I felt so lost. I have now met my match but will def refer newly dx'ed pwMS to this vid 🙏❤️

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 4 lety +2

      :) I am actually old enough to remember that style of practice. Neurologists had the perception that Avonex/Betaseron/Copaxone/Rebif were all the same (which is actually not true as you can tell from the video).

  • @aditya50499
    @aditya50499 Před 2 lety +2

    1 like would not justify the amount of hard work that must have gone into making this comprehensive video. A thank you would do no justice either, but....
    Thanks a mil sir for bringing out such videos for us. 🙂

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 2 lety +1

      I'm glad it was helpful. I originally compiled these articles for a lecture I gave as a fellow many years ago.

  • @erniejoel1234
    @erniejoel1234 Před 4 lety +1

    Love the info. Thank you Dr.

  • @CHRISRepAZ
    @CHRISRepAZ Před 3 lety +2

    Excellent video!! Best I've seen.
    PS I ended year 2 of cladribine 5 weeks back.
    My first MS attack was in 1986

  • @lemonpeelangelfish
    @lemonpeelangelfish Před 2 lety

    Thank you Dr Beaber much appreciate your time putting this together- very interesting!

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 2 lety +1

      I'm glad you enjoyed it. There unfortunately aren't a lot of head-to-head trials for multiple sclerosis drugs in modern times.

    • @lemonpeelangelfish
      @lemonpeelangelfish Před 2 lety

      Yes interesting that - it’s almost like the drug companies don’t want to make it easy to compare on a head to head basis!

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 2 lety

      @@lemonpeelangelfish This type of study would be very expensive, and drug companies have little motivation to do them unless they are certain their drug will come out a winner.

  • @renaezelmar6718
    @renaezelmar6718 Před 9 měsíci

    Echoing all others to thank you for the painstaking work that went into cross-referencing all these studies!
    Thought I was clear of all this comparison once my neuro prescribed kesimpta, but looks like I may run up against some step treatment requirements. So this is super helpful in comparing the efficacy of the first-level treatment options of different insurance plans, as my open enrollment looms near.
    We're a smallish audience, but your effort makes such a big difference ❤

  • @TrollinOn22s
    @TrollinOn22s Před 2 lety +3

    After about 13 years of MS I tried Rebif and that's when neuropathy started. Without meds I had never experienced pain and the worse part is it didn't work, but I've been in pain ever since.

  • @AB-sh1gn
    @AB-sh1gn Před rokem

    You’re Awesome doctor it’s been 2y and I remember seeing the video to choose a medication that’s helped me a lot ♥️♥️♥️ keep going 👍🏻♥️

  • @thegoodolvet5586
    @thegoodolvet5586 Před rokem +1

    Just wanted to say Thank you for doing this and all your other videos for the MS community!!

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před rokem +1

      I'm glad you enjoy them. Let me know if you have a video suggestion.

  • @kathryn6402
    @kathryn6402 Před 3 lety +2

    This ranking definitely mirrors my treatment experience. I’ve only tried Tysabri, Gilenya, Techfidera and Rebif, but I would certainly rate their effectiveness in that order 😁

  • @janetskocy9936
    @janetskocy9936 Před 10 měsíci

    I was diagnosed in 1999, started on Betaseron and took that until 2011. I had a few relapses and multiple new lesions in that decade. Started on Gilenya in 2011, by 2013 no new lesions and my symptoms stabilized. In 2021, during my yearly physical, my doctor found I developed junctional heart rhythm so I stopped Gilenya. I was told it had caused the heart rhythm. Had to have a ton of cardiac tests to make sure the junctional heart rhythm went away, and it did stay gone. Doc started me on Aubagio and 11 months later with zero MRI progression, I had a whopper of a relapse. I was told it may be rebound after stopping Gilenya. So I got a 3 day solumedrol and I moved on to Ocrevus in October 2022. I've been working to get back to where I was in July 2022 before it all fell apart but I think I have lost some ground for good. And being diagnosed with invasive breast cancer last month hasn't helped.

  • @heythereguys1
    @heythereguys1 Před 3 lety

    Hi Dr. Beaber,
    First, thank you for making these videos. They are extremely helpful, espeically with such a... confusing disease.
    I'm a 29 year old male, I was diagnosed a.1.5 years ago. Within 6 months of diagnosis I was going through round 1 of lemtrada. Unfortunately, after day 2 I started experiencing lung swelling and bleeding, which put me in the hopsital (it took the hospital almost a week to figure out it was lemtrada, despite me telling them when I got there.. they almost did a bronchoscopy because they were conviced it was vape lung disease, smh..). With that in mind, I am of course not allowe to continue with lemtrada, and it has been almost a year since I have been on any DMTs.
    I have been looking at zeposia. I know you speak about it here, but I'm curious if you have any thoughts about someone in my situation?

  • @tabirthabrownfield8889

    Great video

  • @mariasawad
    @mariasawad Před 2 lety +2

    Hello Dr. Beaber,
    Thank you for taking the time to prepare these videos, you have no idea how helpful it is for me and anyone else struggling with MS!
    I am 27 years old and was diagnosed with Relapsing Remitting Multiple Sclerosis 1 year ago and have been taking avonex/cinnovex for 9 about months. Unfortunately, the new MRI showed 6 new lesions in the brain (1 of them is currently active) and spinal cord (i am no longer surprised that Interferon_beta-1a did not work for me after seeing the numbers and comparison in your presentation)
    I live in lebanon, and we are currently going through major shortage in all medications. I have the choice to switch to Tysabri or mabthera (generic for rituximab) - tecfidera is also available.
    Do you have any recommendation?
    Thank you for your time.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 2 lety

      I'm glad the video was helpful, but I can't give you specific medical advice here. Both Tysabri and mabthera are considered to be high-efficacy disease modifying therapies. Many people make this type of decision based on concerns about lifestyle and side effects. For someone planning to become pregnant or who has unstable health insurance, tysabri isn't a great option (risk of post-tysabri rebound)

  • @mywaterbaby1
    @mywaterbaby1 Před rokem

    Outstanding ❤

  • @andrewkaldas3337
    @andrewkaldas3337 Před 3 lety +2

    Hi Dr. Brandon Beaber, could you make a video directly comparing Aubagio (Teriflunomide) to Betaseron (Interferon beta-1b) and also comment on any information regarding their differing efficacy (disease progression & lesions) with patients having high BMI (if applicable)?

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety +1

      There is a clinical trial called the TENERE study which compared Aubagio with Rebif (which is similar in efficacy to Betaseron) suggesting they are approximately equally effective: journals.sagepub.com/doi/full/10.1177/1352458513507821 I am not aware on any specific data on how BMI would effect these drugs.

  • @cnt2495
    @cnt2495 Před 3 lety

    Thank you for posting this video! I've been on the edge of which medication to switch to since I've grown tiresome and it's been traumatic injecting copaxone into my body for 5 years. I've been wanting to switch to an oral medication but every time I look at them, they always say that the side effect of an oral medication is a low blood count. Is that common or rare in your patients or from a research point of view?

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety +1

      I depends on the exact medication. For gilenya (and other S1P modulators such as ozanimod, siponimod), a low lymphocyte count is a normal side effect. For Tecifdera (and vumerity, bafiertam), low lymphocytes occur in some but not all. Most people taking aubagio have normal white blood cell counts.

  • @EH_888
    @EH_888 Před 2 lety +2

    I took Avonex for 4 months and absolutely hated it. I felt pretty bad every day except for Thursday and then it all began again on Friday (injection day). I pretty much had no life on that medication and stopped taking it.

  • @yeahruud588
    @yeahruud588 Před 2 lety

    Thank you so much for this collection! Do you also have information on Plegidry? Perhaps it has just another name in your list?

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 2 lety +1

      Plegridy is similar in efficacy to avonex.

    • @yeahruud588
      @yeahruud588 Před 2 lety

      @@DrBrandonBeaber Thanks! Do you have a reference for that? I was told it was similar to Rebif.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 2 lety +1

      @@yeahruud588 There is no head to head trial against either avonex or rebif, so I can't say for sure.

  • @maryc5678
    @maryc5678 Před 4 lety +2

    It is unfortunate that HCST is not more available even though research shows it is effective. Do you see this changing anytime soon? Thanks for this informative video!

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 4 lety +2

      I think it's unlikely. Doctors tend to be extremely risk adverse, and most hematologists want nothing to do with treating autoimmune disease. If there were a head to head trial showing a clear benefit of HSCT over high-efficacy drugs such as rituxan/tysabri/ocrevus/Lemtrada, it might be different, but who would fund such a trial? Also, some people could enroll in the trial and then drop out once they are not assigned to HSCT.

    • @maryc5678
      @maryc5678 Před 4 lety

      @@DrBrandonBeaber Thank you for your response and for your dedication to the MS community!

    • @echicago1294
      @echicago1294 Před 4 lety

      @@DrBrandonBeaber the trial I was in was randomized- participants were told if they were randomized to control drug that if/when the drug failed they would switch over to HSCT arm. Of course the study ended before everyone had a chance to switch over.

    • @quigonjin6030
      @quigonjin6030 Před 3 lety +2

      I had HSCT done at ClinicaRuiz in Puebla Mexico. Top notch facilities. As good or better than US. It didn’t cure me, but others in my group say they have stopped progressing. Biggest benefit was meeting and experiencing this with others with MS. Also, introduced me to Rituxan, which seems to slow my progression. Recommended if you can afford it.

  • @Fabi1701A
    @Fabi1701A Před 3 lety

    Wow, I will be having my 3rd MRI to obtain the official diagnosis according to the neurologist, I am a 54 year old woman, fit, active, no illnesses whatsoever, . , I am 108 lbs. will I survive the side effects?
    Great information, I am very grateful for all your efforts.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety +2

      For most multiple sclerosis disease modifying therapies, the dosing is not weight-based, and being a 108 lbs would not be a problem.

  • @s0phian0va
    @s0phian0va Před 2 lety

    Hi Dr. Beaber. I was wondering what you thought about Chlamydia pneumoniae causing multiple sclerosis?

  • @phallenhay
    @phallenhay Před 2 lety

    Can you go over what the most effective treatment would be for MS patients with severe psoriasis?

  • @1feralleo
    @1feralleo Před 3 lety +1

    Hi Dr Beaber, would you say that Copaxone is the safest therapy with high jcv titer levels like over 2.5? And would you then recommend the daily or every other day injections for efficacy? Thank you great video

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety +2

      There are no known cases of glatiramer (copaxone/glatopa) associated PML, so I don't believe there is any association between PML and this medication, though this is true for several other MS disease modifying therapies. I have no strong opinion about the 20mg daily dose vs. the 40mg three times weekly regimen.

    • @1feralleo
      @1feralleo Před 3 lety

      @@DrBrandonBeaber thank you so much I feel the same about the risk with Copaxone. I feel that my body handled the daily injections better but didn't like doing it daily..lol I really appreciate your time.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety

      @@1feralleo I can certainly understand this as I have tried it myself! czcams.com/video/wvoXFGFwUR4/video.html

  • @mrehak554
    @mrehak554 Před 3 lety +1

    Upon diagnosis about 13 years ago, I was infused with twice daily heavy doses of Solumedrol and then weaned off of an oral steroid.
    The experience led to vowing to never repeat the treatment as it was marked by ruthless side effects.
    I was wondering if you would consider making a video detailing corticosteroids and MS. Is it still used and if so, how is it effective?
    I know that Solumedrol comes with Ocrevus and is probably responsible for that sleepless night I have grown used to on treatment day.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety

      Thanks for the suggestion. I'll make a note of it (I have some other videos I am planning to do first)

  • @quigonjin6030
    @quigonjin6030 Před 3 lety +1

    Wow, an MS specialist I agree with.
    I have PPMS or SPMS depending on my doctor and what drug he wants me on.
    I have had HSCT at clinica Ruiz. I’ve also been on Copaxon, Gilenya and Rituxan.
    Difficult to separate HSCT and Rituxan because Rituxan was a part of my HSCT program.
    Copaxon and Gilenya had no effect.
    I endured HSCT no problem, but it was not a cure for me. Rituxan seems to slow my progression, but have not had an infusion for almost a year due to COVID.
    So my experience was pretty much in line with Dr. Beaber.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety

      Thanks for sharing your experience.

    • @quigonjin6030
      @quigonjin6030 Před 3 lety +1

      Just had an upsetting remote consult with my MS specialist. He does not recommend continuing Rituxan because the MS Society found that 6 of 93 people on Rituxan that got COVID have died and that he didn’t think Rituxan worked. He also wants me to be part of a phase 3 trial by Roche for Fenebrutinib? I feel totally lost now. I’m not sure that Rituxan helped me, but believe it’s the only DMD that didn’t hurt me. I don’t trust Roche because of the Ocrevus/Rituxan scam. I’m on the cusp of losing my ability to walk and don’t know what to do next.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety

      @@quigonjin6030 :( Sorry to hear you are in a difficult spot. Things are very complicated with the COVID-19 pandemic. I wish you the best of luck.

  • @Py16777216
    @Py16777216 Před 2 lety

    I would like to get #1 prescribed as I highly agree that it is the best option in terms of efficacy over a short term and over a long term without additional treatment or perhaps a repeat treatment every few years. I can't afford it out of pocket though. I responded surprisingly well to IVIG but I recognize it's not often very effective in MS over a population. Is it possible that IVIG could partially reprogram or alter a faulty immune system in very unusual cases?

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 2 lety

      It's hard for me to answer this, but I am skeptical that IVIG has any benefit to anyone with MS (aside from treatment of hypogammaglobulinemia in people taking b-cell depleters to prevent infections).

  • @pitapita3559
    @pitapita3559 Před 2 lety

    Hello Dr. Brandon Beaber, my neurologist is thinking I am in the secondary progressive phase, and I am considering siponimod for treatment but I have the jc virus and don't want PML. Have there been cases of PML with Siponimod, or else in Ocrevus? Year after year I am less able to continue walking, now past 10 min I have to sit down. Without distinct new evidence for relapse on a scan, I am avoiding more gad enhancing MRI because of the associated risks of doing this more than once. History wise I have been on Betaseron, switched to Aubagio, and am trying to work out what to do. Please let me know if there is any info I can provide to help you to recall what would be good for me to know. Thank you.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 2 lety +1

      I'm not sure about reported cases of PML with siponimod, but there is likely a very small risk (~20,000:1 with the similar medication gilenya). I am aware of only a single case of PML in someone taking ocrevus who had not previously received tysabri.

  • @ansi1214
    @ansi1214 Před 5 měsíci

    Dear Dr., is there a new update in your Ranking ? Do you think Cladribin Had Shown some advantages in comparison to anti cd20 Therapies ? There are some ms experts who recommend bzell depleaters as First line And another expert from the Uk. is more for Cladribin Starting. Thanks for Feedback And best wishes from germany!

  • @fantomblack
    @fantomblack Před 2 lety +1

    Can you do a video on Biotin, the studies they are doing and what they have found so far please? Thank you

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 2 lety

      I already did one in 2020. Here is the link: czcams.com/video/CS6CWPBHKGM/video.html

  • @Caro-hf2sp
    @Caro-hf2sp Před 3 lety +1

    Based on this do you recommend HSCT or Alemtuzumab to all your patients?

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety

      No. Safety is also a consideration, not just efficacy.

    • @amydascalos3964
      @amydascalos3964 Před 3 lety +1

      @@DrBrandonBeaber None of these are safe...they all lead to yearly brain loss...and secondary progressive ms and right into an institution.

  • @meghalaroia5188
    @meghalaroia5188 Před 4 lety

    Goodevening doctor, does tecfidera 120mg twice a day gives almost similar result as tecfidera 240mg, since I'm unable to tolerate 240mg considering hair loss and heartheartburn. Please advise.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 4 lety

      To be honest, I am not aware of any specific data on the 120mg twice a day dose.

  • @DMhockey33
    @DMhockey33 Před 4 lety +2

    Has scheman growth hormone ever been studied with MS? I read that it has neuroprotective qualities and also may promote remyelination

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 4 lety

      Not that I know of, and a quick search doesn't bring anything up.

  • @leasena9787
    @leasena9787 Před 2 lety

    I have been on Glatect for almost two years now and I have to inject myself daily. I’m looking into changing to a different therapy. What would you recommend? I will be going to see my neurologist to get results from new MRI and I would like to request to change meds.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 2 lety +1

      I can't give you personal advice here, but hopefully this video gave you some ideas to discuss with your neurologist. I wish you the best of luck.

    • @leasena9787
      @leasena9787 Před 2 lety

      Yes I did. Thanks a lot for a very educated vídeo about the MDT. 🙏🏽

  • @rickjillson9336
    @rickjillson9336 Před rokem

    I would love to hear your thoughts on the recent CAR-T study results in mice.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před rokem

      thanks for the suggestion. I would have to look into this. Do you have a reference you would like me to look at?

  • @tabbylynn4130
    @tabbylynn4130 Před 2 lety

    Is there any way I could show you part of my mri study and you give me your opinion. I have severe emphysema and recently diagnosed with ms but I feel like the brain lesions could be due to 02 loss and severe central sleep apnea.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 2 lety +1

      Unfortunately I can't give you personal advice here

  • @melchieempiales5749
    @melchieempiales5749 Před 8 měsíci +1

    Hello Dr. I’m from the Philippines and i was diagnosed with NMOSD . I want to ask if the itchyness can go away? the left side of my head is really itch . i had this before i was diagnosed. PLEASE RESPOND I NEED AN ANSWER 🙏🙏🙏😭

    • @elvinashourn4673
      @elvinashourn4673 Před 7 měsíci

      I recommend to you all Dr Ehimare herbs on CZcams channel that get my husband cured after the usage of herbs medicine treatment from Dr Ehimare on CZcams channel also get in touch with him ❤️

  • @annaconsta
    @annaconsta Před 3 lety +1

    Doesn't Interferon 3 times a week suncutaneously make your liver explode? I currently am on Avonex, only once a week intramuscular, and the day after the injection i have no appetite and sometimes am nauseous.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety

      Most people taking high dose high frequency interferons don't have liver problems, but it is a possible side effect.

    • @annaconsta
      @annaconsta Před 3 lety

      @@DrBrandonBeaber Thank you very much!

  • @pitapita3559
    @pitapita3559 Před rokem

    Hi Dr. Beaber, could you please tell me where you would personally place Kesimpta in your ranking? Which number? Thank you very much.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před rokem +2

      roughly equal with other b-cell depleters (rituximab, ocrevus).

    • @pitapita3559
      @pitapita3559 Před rokem

      @@DrBrandonBeaber of these b-cell depleters , may I ask what would you personally reason to guess to be the least likely to lead to PML? I realized we have more data for some drugs than others but because you know how these work I would be interested in what you think are more risky in the aforementioned way.

  • @phalabowles7942
    @phalabowles7942 Před 4 měsíci

    How do I get an appointment with you. Very unwell and unable to get the help I need.

  • @DrBrandonBeaber
    @DrBrandonBeaber  Před 4 lety +6

    If you would like a source for one of the articles that is not in the video description, let me know, and I would be happy to reply with a link.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety

      @Nutshell _ Thanks for sharing your story, and I hope you continue to do well.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety

      @Nutshell _ I don't see how familial mediterranean fever could be confused with MS.

    • @annaconsta
      @annaconsta Před 3 lety +1

      Could you please make a comparison Tysabri versus Ocrelizumab? Or if there already is such a video, could you please give me the link? I would immensely appreciate it. I am on Avonex and it is not very effective. My neurologist said i could try Tysabri or Ocrelizumab if i wanted to. Ocrelizumab is basically chemotherapy so chances are very low i would even consider it. But still, i would love a comparison between the two, it would help me make a decision, or not make any decision whatsoever.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety +2

      @@annaconsta I'm not aware of any study directly comparing these medications. Ocrevus has slightly better data in terms of prevention of gadolinium enhancing lesions, but my personal opinion is that they are about equally effective. I do have separate videos on each of these medications if it would help you. Ocrevus: czcams.com/video/mCVVvq7Aov0/video.html Tysabri: czcams.com/video/LIKPYQFVNCQ/video.html

    • @lindavanzwol2643
      @lindavanzwol2643 Před 3 lety

      I would like to know more on the safety profile of aHSCT. The current status in the Netherlands is that aHSCT is denied to MS patients because its too dangerous.
      Euthanasia is offered to MS patients tough...
      So the dutch patients have to pay/ crowdfund themselves, and go to moscow or mexico for treatment. With no objective discription of the negative dangers....

  • @nardososa8649
    @nardososa8649 Před 3 lety +1

    What is the “best “ oral MS medicine? I’m on tysabri infusion, but I’m trying to find a oral medication

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety +1

      They haven't been compared head-to-head against other oral agents but most likely the s1p receptor modulators (gilenya, ozanimod, mayzent)

    • @nardososa8649
      @nardososa8649 Před 3 lety +2

      I have been on tysabri for13 years, and have just now tested positive for the Jaycee virus, and I’m moving to an oral medication

  • @grzegorzporada
    @grzegorzporada Před 3 lety

    Do you think that is a long way to approve HSCT as a one of the standard treatment?

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety +2

      HSCT isn't a single treatment, so I don't think it would ever be FDA/EMA approved. HSCT is essentially a class of different treatments which could be described as "immune rebooting therapy." HSCT could become more popular if it could defeat a high-efficacy disease modifying therapy such as Lemtrada in a randomized trial, but I don't know who would fund this trial.

    • @amydascalos3964
      @amydascalos3964 Před 3 lety

      @@DrBrandonBeaber fda only approves food/drugs not procedures..the drug CYC chemo is already fda approved....Lemtrada is 50% effective hsct is 70% at 5 years....people w/low cd8 counts fail hsct at 5 years...those w/ ultra low cd 8 just non-respond at the start... cd 8+ cells control EBV.

  • @AB-sh1gn
    @AB-sh1gn Před rokem

    Thank you doctor could you do the best drugs 2023 for updates 🙏🏻🙏🏻🙏🏻 please

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před rokem

      Thanks for the suggestion. I may do an update to this video

  • @9NIAF
    @9NIAF Před 4 lety +3

    Someone said that you can as multiple Sclerosis patient live without medication just depends on healthy diet and slightly exercise with less stress.. it seems a good idea but kind of afraid to do it!

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 4 lety +3

      I do have a playlist on nutrition and MS if you would like to take a look: czcams.com/video/Cey5muWJBs0/video.html

  • @andrewkaldas3337
    @andrewkaldas3337 Před 3 lety

    Hi Dr. Brandon Beaber, I was wondering how would this list change if it was specifically for someone who has a BMI of about 40? (5 ft 11" /290lbs) Thank you very much.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety +1

      It probably wouldn't change much. There is some evidence based on a retrospective analysis that the drug Ocrevus may be less effective in people with a higher body mass index, and this is being researched further.

    • @andrewkaldas3337
      @andrewkaldas3337 Před 3 lety

      ​ @Dr. Brandon Beaber Should I still personally consider taking Ocrevus or would another med likely make more sense? Thanks.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety +1

      @@andrewkaldas3337 I unfortunately can't give you personal medical advice here. I personally would take into account body weight much in making my recommendations.

    • @andrewkaldas3337
      @andrewkaldas3337 Před 3 lety

      @@DrBrandonBeaber Understandable, I will ask about the studies mentioned when next I meet my neurologist. Thank you.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety +2

      @@andrewkaldas3337 Here is the link to the article: www.ncbi.nlm.nih.gov/pmc/articles/PMC6469695/ "significant treatment-by-subgroup interactions for BMI indicate that the magnitude of ocrelizumab treatment benefit is greater in lighter patients versus heavier, consistent with lower ocrelizumab exposure in heavier patients (BMI > 25 kg/m2 versus

  • @antonyraj55
    @antonyraj55 Před rokem

    Can a patient using gilenya switch to rebif or is gilenya a stronger medication?

  • @ilovegodzilla
    @ilovegodzilla Před 4 lety

    My husband is on Extavia for RRMS. Would one of the other meds work better?

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 4 lety

      I can't give you any direct medical advice here. There are certainly many medications believed to be more effective than extavia, but there are other considerations (safety of the medication, other medical conditions, the specific history of multiple sclerosis, individual preferences).

    • @ilovegodzilla
      @ilovegodzilla Před 4 lety

      @@DrBrandonBeaber Thank you.

  • @afonsor1540
    @afonsor1540 Před 3 lety

    Hello. Can you compare Copaxone with Aubagio and Tecfidera? Thanks

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety +1

      If you skip to 9:00, I compare Tecfidera Vs. Copaxone. There is no head to head trial with Aubagio except Aubagio vs. Rebif (10:22)

    • @afonsor1540
      @afonsor1540 Před 3 lety

      @@DrBrandonBeaber Thanks for the answer. I saw the comparisons you told me, in fact I saw the full video. I would like to know which of the medications (Copaxone, Aubagio, Tecfidera) is the best in your opinion. Thanks

  • @Itsme1.
    @Itsme1. Před 2 lety +1

    The doctor give me list of medications and told me to choose and i read alot about all meds and I choose to start with tecfidera hope it be helpful for me

  • @demoskunk
    @demoskunk Před 4 lety

    Why doesn't HSCT work on PPMS? Is the disease purely neurodegenerative at that point, and not autoimmune?

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 4 lety +1

      The theory is that systemic inflammation is less important in PPMS and that inflammation within the central nervous system compartment, mitochondrial failure, and other local factors are driving progression. I am going to publish a more detailed video on HSCT shortly. There is a pilot study in progressive MS published in 1997 with BEAM + ATG (median age 37, median EDSS 6) showing a possible modest benefit, but there was extremely poor follow up, limiting interpretation of the data. Here is the link: www.nature.com/articles/1700944.pdf

    • @CFinckelstein
      @CFinckelstein Před 4 lety +1

      @@DrBrandonBeaber What? This study is over 20 years old, very positive and then ignored by our scientists? What is wrong with us? Thanks a lot for the link.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 4 lety +1

      @@CFinckelstein I'll show the data in a little bit more detail in the upcoming video. Like I said, there was very high dropout rate, so it is very difficult to tell if there was any benefit to the treatment. Often, people who have better results with an intervention are more likely to come to the follow up visits.

    • @CFinckelstein
      @CFinckelstein Před 4 lety

      @@DrBrandonBeaber good point. Thanks for reply. And keep on your amazing work

  • @larrytate1657
    @larrytate1657 Před 2 lety

    Is it possible if you’re still having trouble on ocrevus that rebif may work better for you?? Thanks

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 2 lety

      Overall, Ocrevus is more effective than Rebif based on the OPERA I/II studies, but an individual can always have better results on an individual medication.

    • @Sbannmarie
      @Sbannmarie Před 2 lety

      I know three people on It all with Good reviews

  • @TanyaMarieP
    @TanyaMarieP Před 3 lety +1

    How do you feel about clemastine after AHSCT?

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety

      I have a separate video on clemastine: czcams.com/video/T6p5e2TcR9Q/video.html I don't have any specific opinion on using it after aHSCT.

  • @andrewkaldas3337
    @andrewkaldas3337 Před 2 lety

    Hi Dr. Beaber, for Active Secondary Progressive MS *specifically* could you please comment on the difference in efficacy (+ risk if time permits) between Ocrevus vs Mayzent?

  • @bluesky6985
    @bluesky6985 Před 3 lety +3

    High dose 50000 to 300000 units of vitamin D are be being used.

  • @perrymurton7730
    @perrymurton7730 Před 2 lety

    Thoughts on Riximyo?

  • @emilye709
    @emilye709 Před 2 lety

    I would not consider it to be the best without considering side effects.

  • @Elegantae2012
    @Elegantae2012 Před 3 lety +1

    Hey I’m a recent diagnosed ms and I’m choosing what treatment to go for yet I’m thinking mavenclad however I wanna try herbal supplements?

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety +1

      I can't give you any personal advice, but I wish you the best of luck regardless of what you decide

    • @nawidsahargul8599
      @nawidsahargul8599 Před 2 lety

      Hi sister,
      I am also thinking of mavenclad. Did you start the treatment?

  • @810connie
    @810connie Před 3 lety

    could you share a link to a comparison of Ocrelizumab to Rituximab/Truxima? I wanted to know more about the long term studies of rituximab

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 3 lety

      I am not aware of any specific trial comparing them, but in Sweden, they have many publications on long-term use of rituximab in MS as in this publication on de-escalation: link.springer.com/article/10.1007/s00415-021-10399-8 ECTRIMS 2019 actually had a debate on this subject (somewhat biased in my opinion): multiplesclerosisnewstoday.com/news-posts/2019/10/04/ectrims2019-is-rituximab-a-reasonable-option-for-ms-patients

  • @mirkasecret1
    @mirkasecret1 Před 3 lety +1

    Hello, I was on avonex, made my depression horrible, changed neurologist.. she said to stop avonex now, because it’s not good especially for depression. She wants to put me on Tysabri ASAP but I’m terrified of it only because read all the side effects and they are scary, I’m JCV negative. I’m not sure about this medication and wonder if anyone here is on Tysabri infusion? How do you like it, do you see any positive results or negative too. How did the infusion feel, how long are you on it? I’m going crazy to find out more about it. I scheduled another appointment with my doc to talk about it more. I’m confused 🥺. Help please !!

    • @kathryn6402
      @kathryn6402 Před 3 lety

      Hi Mirka. I’ve been on Tysabri for 5 years and I have a friend who’s been on it 12 years. Both JC negative and neither of us have clinically progressed since starting. It appears to be quite safe in JC negative people, and, even though risks go up with years of use, if you know the symptoms of PML then you can look out for them. Apart from PML, the risks are less than the other IV treatments (that often carry risks of malignancy along with PML). I truly wish you the best in this decision! 😁

    • @kathryn6402
      @kathryn6402 Před 3 lety

      Oh, and as to what it feels like... nothing! It doesn’t feel like anything has happened - no pain, no reactions (although my friend occasionally feels allergy type symptoms that are easily mitigated by concurrent IV antihistamines). I can feel the saline more than the Tysabri because the saline is cold hahaha. Sometimes I feel tired for 24 hours afterwards, but occasionally I am energised. I notice symptoms creeping back in (mainly fatigue) towards the end of every month, so I’m always looking foreword to topping up my tank!

  • @lush462
    @lush462 Před 3 lety

    Great. Primary Sjogren has none.

  • @gabbyfranks78
    @gabbyfranks78 Před 4 lety

    Are you a neurologist

  • @msforyou2578
    @msforyou2578 Před 3 lety +1

    I'm from India . i have MS please give me zeposia . i want to live my life peacefully

  • @StrangerOnO
    @StrangerOnO Před rokem

    Kesimpta?

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před rokem

      This video predates the approval of kesimpta

    • @StrangerOnO
      @StrangerOnO Před rokem

      @@DrBrandonBeaber sorry I was sent this by someone else so I'll ask do you have any video that talks about kesimpta?

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před rokem

      @@StrangerOnO Kesimpta (Ofatumumab) for Multiple Sclerosis [ASCLEPIOS I/II trial results]: czcams.com/video/IIBBlvnPjS0/video.html Ocrevus vs. Kesimpta for Multiple Sclerosis. Comparison Between the Drugs, Efficacy, Side Effects: czcams.com/video/BVhN4_sEi1s/video.html

  • @tumbleweed7283
    @tumbleweed7283 Před rokem

    Mm

  • @JG-ix5xr
    @JG-ix5xr Před 3 lety +3

    You lost me at “we are not going to look at side effects” bye ✌️

  • @jasonc5289
    @jasonc5289 Před 4 lety +1

    Do you know where the US is in health care? 37th. I especially like the study from 2017 where we rank 54th. You should be in jail. In the Ukraine they discovered the cure for MS in 1987. Again, you should be in jail.

    • @roberture5903
      @roberture5903 Před 4 lety

      Jason, I would love to know the cure Ukraine found in 1987. If that's the case I would quit all my meds.

    • @DrBrandonBeaber
      @DrBrandonBeaber  Před 4 lety +6

      ???

    • @jasonc5289
      @jasonc5289 Před 4 lety +1

      @@DrBrandonBeaber You should go to prison.

    • @roberture5903
      @roberture5903 Před 4 lety

      Jason it is my opinion that have no right saying to Brandon. Between him and Aaron Boster, they are doing everything they can to help those of us impacted by ms.

    • @jasonc5289
      @jasonc5289 Před 4 lety

      @@roberture5903 They rank 37th in health care. Again, I like the study from 2017. Follow Dr. Terri Wahls, Dr. George Gelinik (sp?), or Matt Embry. Follow their protocols. If you need further help, go to Clinica Ruiz for HSCT and if you need further, go to EmCell in the Ukraine.

  • @jasonc5289
    @jasonc5289 Před 4 lety

    This is telling:
    czcams.com/video/i0m_isndqc0/video.html
    Again, you should be in jail.

  • @johnathanlee5478
    @johnathanlee5478 Před 24 dny

    I have so many lesions it’s hard to count at first I got double vision and loss of feeling in hands 8 days of solumedrol I got everything back immediately got on copaxone. 13 years no relapses, hard to believe because of lesions financial reasons stopped taking it and started zaposia been on that now 1 year feel the same nothing has changed except I don’t give shots anymore thank god🙏now just a tiny pill. So in my opinion copaxone and zaposia are number one. I’d like to read others opinions please and thank you.